From the Princess Margaret Hospital/University Health Network, University of Toronto, Toronto; National Cancer Institute of Canada Clinical Trials Group, Queens University, Kingston, Ontario, Canada; and OSI Pharmaceuticals Inc, Boulder, CO (At 2008-05-10)
